Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old
Van Oorschot, Desirée, Anastassopoulou, Anastassia, Poulsen Nautrup, Barbara, Varghese, Lijoy, von Krempelhuber, Alfred, Neine, Mohamed, Lorenc, Stéphane, Curran, DesmondLanguage:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2018.1509645
Date:
August, 2018
File:
PDF, 1.80 MB
english, 2018